# Efficacy and Safety of Dingkundan Combined With Combination Oral Contraceptives in the Treatment of PCOS

> **NCT05872425** · NA · COMPLETED · sponsor: **Guangdong Women and Children Hospital** · enrollment: 120 (actual)

## Conditions studied

- PCOS

## Interventions

- **DRUG:** DingKunDan(GuangYuYuan)
- **DRUG:** Drospirenone and Ethinylestradiol Tablets (Ⅱ)

## Key facts

- **NCT ID:** NCT05872425
- **Lead sponsor:** Guangdong Women and Children Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-01
- **Primary completion:** 2024-04-01
- **Final completion:** 2024-04-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2024-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05872425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05872425, "Efficacy and Safety of Dingkundan Combined With Combination Oral Contraceptives in the Treatment of PCOS". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT05872425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*